international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress



Overview | Agenda | Promotional Opportunities | Grantors & Exhibitors
Admin | Speaking Proposals | Continuing Education | Past Conferences | Contact Us | Home






TENTH INTERNATIONAL PHARMACEUTICAL COMPLIANCE CONGRESS

May 10 - 12, 2016

ATTEND ONSITE
Hilton Warsaw Hotel and Convention Centre
Warsaw, Poland
KEYNOTE SPEAKERS

Adrian Baboi-Stroe, MA, MPP
Secretary of State, Ministry of Justice, Author, "Corruption and Anti-corruption Policy in Romania" in Monitoring EU Accession Process: Corruption and Anti-Corruption Policy, Bucharest, Romania

Sadek Beloucif, MD
Professor, Department of Anesthesiology and Critical Care Medicine, Avicenne University Hospital, Chairman, Ethics Committee of the Biomedicine Agency, Paris, France

Laura Cordova, Esq.
Assistant Chief, Houston and Dallas Strike Force, Corporate Matters, US Department of Justice, Washington, DC

Peter Dieners, Esq.
Partner and Head, Global Healthcare and Life Sciences Group, Clifford Chance, Co-chair, Legal Affairs Focus Group (LA FG), EUCOMED, Co-chair, Compliance Network (CN), EUCOMED, Düsseldorf, Germany

Dr. Krzysztof Landa
Vice Minister of Health in Charge of Drug Policy, Polish Ministry of Health; Founder, Watch Health Care Foundation, Warsaw, Poland

James McDonald, Esq.
Trial Attorney, Criminal Division, Fraud Section, US Department of Justice, Washington, DC

Sophie Peresson, LLM, MA
Director, Pharmaceuticals & Healthcare Programme, Transparency International UK, London, UK

Marie-Claire Pickaert
Deputy Director General and Chief Financial Officer, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium

Pawel Sztwiertnia
Chief Executive Officer, Employers' Union of Innovative Pharmaceutical Companies (INFARMA), Former Undersecretary of State, Polish Ministry of Health, Warsaw, Poland

EFPIA CODES TRAINING WORKSHOP
The European Federation of Pharmaceutical Industries and Associations (EFPIA) is offering an independent EFPIA CODES TRAINING WORKSHOP on Tuesday, May 10, 2016.
  • What can we learn from each other?
  • Come and find out practical cases to help improve your understanding of the Codes, their implementation by national associations and global requirements.
  • Each section will include a presentation of a relevant case from national associations and a description of the relevant requirements from the IFPMA and/or EFPIA Codes, as well as the national codes.
Click here for more information.

CHIEF COMPLIANCE OFFICERS

Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma plc, Former VP, Chief Compliance Officer, Dendreon, Former Associate General Counsel and Executive Director of Compliance, Seattle Genetics, Chicago, IL, USA

Ann Beasley
Chief Compliance Officer, Biogen, Former Global Compliance Officer, Novartis Pharma AG, Board Member and Co-chair, Strategic Committee International Society of Healthcare, Ethics, and Compliance Professionals (ETHICS), Cambridge, MA, USA

Dante Beccaria
Global Compliance Officer and Vice President, Sanofi, Former Vice President of Internal Audit, Sanofi, Paris, France

Eric Cornut, LLM
Chief Ethics, Compliance & Policy Officer, Novartis, Former Chief Commercial Officer, Novartis, Basel, Switzerland

Martin Fürle, MBA (Berlin)
General Counsel and Chief Compliance Officer, Vice President Risk & Compliance, Daiichi Sankyo Europe GmbH, Munich, Germany

Alessandra Hawthorne, Esq.
Global Chief Ethics and Compliance Officer, Boehringer Ingelheim, Ingelheim, Germany

Dominique Laymand, Esq.
Senior Vice President, Chief Ethics and Compliance Officer, Ipsen; President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France

Maureen McGirr, Esq.
Vice President, Office of Ethics, Global Compliance Organization, Merck & Co., Inc., Kenilworth, NJ

Uffe Kåre Rasmussen, M.Sc.
Senior Director and Chief Compliance Officer, H. Lundbeck A/S, Former Principal Scientist, Novo Nordisk A/S, Copenhagen, Denmark

Ilya Yuffa, MBA
Vice President, Global Ethics and Compliance Officer, Eli Lilly and Company, Indianapolis, IN, USA

GLOBAL ANTICORRUPTION UPDATE

Ted Acosta, Esq.
Americas Vice Chair, Risk Management and Global Leader, Life Sciences, Fraud Investigation and Dispute Services, EY, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France

Cristian Ducu, PhD
General Manager, Centre for Advanced Research in Management and Applied Ethics; Founding Member, European Ethics & Compliance Association, University of Bucharest, Bucharest, Romania

Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA

Michael K. Loucks, Esq.
Partner, Skadden Arps LLP, Former Acting United States Attorney, District of Massachusetts, United States Department of Justice, Washington, DC, USA

Paul J. Melling, Esq.
Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia

Vivian Robinson, Esq.
Queen's Counsel, Partner, McGuire Woods, Former General Counsel of the UK Serious Fraud Office, Former Head, QEB Hollis Whiteman Chambers, Recorder of the Crown Court and Treasurer of Inner Temple, London, UK

THE NEW PHARMA MARKETPLACE

Lee Betteridge
Director, Pharmaceuticals and Life Sciences, PwC, London, UK

Hanim Edoo, MSc.
Consultant, MediQualite, Paris, France

Maarten Meulenbelt, Esq.
Partner, Food, Drug, and Medical Device Regulatory Group, Sidley Austin LLP, Brussels, Belgium

Frank Wartenberg, PhD
President, Central Europe, IMS Health, Frankfurt/Main, Germany

Andrew White
Head of Medicine Management - NHS, Greater Manchester Commissioning Support Unit, Manchester, UK

Olivier Wong, MD, MSc
CMO, MediQualité Omega, Early engagement, HTA technology transfer Consultant, Former Voting member, French Transparency committee, Former French guidelines committee member (HAS, ANSM), Paris, France

PERSPECTIVES ON TRANSPARENCY FROM POLAND

Professor Jacek Jassem, MD, PhD
Head, Department of Oncology and Radiotherapy, Medical University of Gdansk; Former President, Polish Society of Oncology, Gdansk, Poland

Dr. Krzysztof Landa
Vice Minister of Health in Charge of Drug Policy, Polish Ministry of Health; Founder, Watch Health Care Foundation, Warsaw, Poland

Dr. Grzegorz Makowski
Director of the Public Integrity Program, Stefan Batory Foundation, the Local Partner with Transparency International in Poland, Warsaw, Poland

Pawel Sztwertnia
Director General, INFARMA; Former Undersecretary of State, Polish Ministry of Health, Warsaw, Poland

PLENARY SESSIONS
  • Overview of the EU, CEE and MEA Anti-Corruption Landscape
  • The National Anti-Corruption Strategy of Romania
  • US Department of Justice Anti-Corruption Update
  • Anti-Corruption Roundtable: Strategies to Foster Compliance
  • Challenges in the New Marketplace 2.0 Ethics and the Current Industry-Physician Relationship Models
  • EFPIA Keynote: Reflections on the Eve of Transparency
  • Perspectives on Transparency from Poland
  • Transparency International Keynote
  • Chief Compliance Officer Roundtable
  • Report from Compliance Survey Commissioned by Ethics
  • Updates on Global Codes
INTERNATIONAL PHARMA
CONGRESS IS

MINI SUMMITS
  • Examining an Investigation from All Sides
  • Annual CEE Compliance Update
  • New Strategies for Integrated Assessment and Management of Risks
  • Patient Programs - Managing Risks of Getting Closer to the Patient
  • Annual MEA Compliance Update
  • Anti-Corruption: Contracting with Third Parties and Optimizing the Relationship
  • Introduction of a New Product into the New Marketplace
  • Data Privacy Case Study: Transferring Data Post the EJC Safe Harbour Ruling
  • Cultural Implications of Compliance Programs across Different Countries
  • Using Predictive Analytics to Enhance Risk Management
  • Third Party Relationships: Cross-Border Engagements, FMV, Monitoring and Auditing
  • New Ethics-Based Approaches to Policies and Training
  • Medical Devices: The Changing Enforcement Landscape
  • R&D Compliance: Case Study on Clinical Trial Data Disclosures
  • Using the Data to Provide Value and Partner with the Business

FEATURED FACULTY

Anthony Alvizu, CPA, EnCE, CFE
Managing Director, Global Risk & Investigations Practice, FTI Consulting, Chicago, IL, USA

David Andersen
Partner, Pharmaceuticals and Life Sciences, PwC, London, UK

Marc Bartel, LLM, MBA
Managing Partner France, Partner, Legal and Board Practices, Heidrick & Struggles, Paris, France

Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY

Ela Bochenek, Esq.
Vice President, Global Compliance, Insmed Incorporated, Bridgewater, NJ, USA

Przemyslaw Bochenski
Medical Director, Abbvie, Warsaw, Poland

Julie Bonhomme, Esq.
Legal Affairs and Compliance Deputy Director, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium

Rifat Bozacioglu
Deputy Compliance Officer, ME Pharma, GSK, Istanbul, Turkey

Olivier Chaduteau
Managing Partner, Day One, Mentor for Entrepreneurs, IME (French Chamber of Commerce), Lecturer, Sciences Po Law School, Paris, France

Tanya Daniels, Esq.
Senior Legal Director, EU Head of Data Protection, Deputy Global Chief Privacy Officer, Quintiles, Reading, UK

Zeynep Didem Degirmencioglu, LLM
Regional Head of Group Compliance, Intercontinental Region, Merck Serono, Istanbul, Turkey

Kip Ebel, MBA
Principal, Fraud Investigation & Dispute Services, EY, New York, NY, USA

Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK

George Fife
Executive Director, Fraud Investigation & Dispute Services, EY, Former Executive Director, Compliance & Ethics, Bristol-Myers Squibb, Paris, France

Elvan Sevi Firat
Founding Partner, Firat - Izgi Attorney Partnership; Board Member, Transparency International Turkey Section, Istanbul, Turkey

Betania Glorio, Esq.
Senior Director Legal and Compliance, EMEA, Raptor Pharmaceuticals, Former Senior Director Compliance, Europe, Middle East and Africa, Onyx Pharmaceuticals, Former Senior Corporate Counsel, Regional Compliance Director, EUCAN, Pfizer, Amsterdam, Netherlands

Cécile Gousset
Associate Vice President, Compliance Risk Assessment, Education and Monitoring, Global Ethics & Business Integrity, Sanofi, Paris, France

Ulf H. Grundmann
Partner, Life Sciences Practice Group, King & Spalding LLP, Frankfurt am Main, Germany

Chris Holmes
Director, Navigant Consulting, Inc., London, UK

Carl Judge
Director, Fraud Investigation & Dispute Services, EY, London, UK

Suzana Junaci, MD
Ethics and Compliance Officer, Eli Lilly and Company, Zagreb, Croatia

Anita K. Kim-Reinartz
Partner, Fraud Investigation & Dispute Services, EY, Düsseldorf, Germany

Isaure Kergall-Gayet
Compliance and Business Integrity Director France, Sanofi, Members, Strategic Committee, ETHICS, Former Vice President, Chief Ethics and Compliance Officer, Ipsen, Paris, France

Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC

Tomasz Kruk, MBA, LLM
Head of Compliance, Vifor Pharma, Former Director International Compliance, Mallinckrodt Pharmaceuticals, Former Director Global Ethics & Compliance, Actavis plc (now Allergan plc), Zürich, Switzerland

Edoardo Lazzarini, PhD
Compliance Initiative Director EUCAN, Takeda Pharmaceuticals International, Former Compliance Officer EMEA (Europe, Middle East & Africa), Biomet, Milano, Italy

Christine Longawa, CPA, CFE
Associate Director, Healthcare & Life Sciences Disputes, Regulatory, Compliance and Investigations, Navigant Consulting, Inc.. Chicago, IL, USA

Maurits J.F. Lugard, MA, JD, LLM
Partner and Lead, EU Life Sciences Regulatory Team, Sidley Austin LLP, Former Member of the European Commission's Legal Service, Brussels, Belgium

Abdul Luheshi, MBA
Director, Life-Sciences, Regulatory Compliance, KPMG UK LLP, Former Vice President, Health Care Compliance, Johnson & Johnson, Former Co-chair, Asia Pacific Pharma Compliance Congress, London, UK

Fiona Maini, M.Sc.
Director, Risk Advisory, Deloitte, London, UK

Daniela Fabian Masoch, Esq.
Founder and Managing Director, Fabian Privacy Legal GmbH, Member and Chapter Co-Chair, International Privacy Professionals Association (IAPP), Former Global Head Data Privacy, Novartis International AG, Basel, Switzerland

Laura Nassar
Head of Compliance, Middle East, Hoffmann-La Roche Ltd., Dubai, UAE

Michael O'Connor
Senior Director, Ethics and Compliance Operations, Alexion Pharmaceuticals, Inc., Cheshire, CT

John Patrick Oroho, Esq.
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ, USA

David O'Shaughnessy
Vice President, Compliance, Emerging Markets, Quintiles, Board Member, ETHICS, Former Vice President Compliance, International Pharmaceuticals, GSK, Former Vice President, Global Compliance Strategy, AstraZeneca, Reading, UK

Giota Papamarkou
Global Ethics & Compliance Director, Ipsen, Former EMEA Compliance and Ethics Manager, Bristol-Myers Squibb, Paris, France

Ima Parrondo
Health Care Compliance Officer EMEA-C, Janssen Pharmaceutical Companies of Johnson & Johnson, Madrid, Spain




Minal Patel
Compliance Officer, Pharmaceuticals & Consumer, South Africa & Sub Saharan Africa, Johnson & Johnson, Johannesburg, South Africa

Piergiorgio Pepe, LLM
EEMEA Compliance Area Director, Office of Ethics and Compliance, AbbVie, Former Director, Compliance and Ethics, EMEA, Bristol-Myers Squibb, Paris, France


Oscar Perdomo
Director, Pharmaceuticals and Life Sciences, PwC, Switzerland

Maria Teresa Rico Perez, MD
Europe and Canada Regional Compliance Officer, Biogen, Zug, Switzerland

Madina Plieva, PhD
Legal and Compliance Director, Russia, Bristol Myers-Squibb; Former Legal Director, Association of International Pharmaceutical Manufacturers (AIPM); Former Head of Legal, Department, Kutafin Moscow State Law Academy, Moscow, Russia

Katalin Pungor, MD, PhD, MBA
Director, Healthcare Compliance, Emerging Markets and CEE, Johnson & Johnson, Budapest, Hungary

Ariadna Quesada, MPP
Compliance Manager Europe, Middle-East, and Africa, MicroPort Orthopedics Inc., Amsterdam, Netherlands

Nathalie Raynaud
Corporate Compliance Officer, Ethics & Business Integrity Department, Sanofi, Paris, France

Fabien Roy, DESS, European Law
Senior Associate, Hogan Lovells, Brussels, Belgium

Abdallah El Saadi, CCP
Regional Compliance Officer - Middle East, Turkey and Africa, Boehringer Ingelheim, Dubai, UAE

Daniel Schafaghi
Global Compliance Operating Officer, Head of Compliance Emerging Markets, Boehringer Ingelheim GmbH, Ingelheim, Germany

Ben Shoshan
Director/Owner, Consultant and Executive Coach, Open Water, London, UK

Hubertus Stockmann, MBA
Divisional Compliance Officer, Merck KgaA, Frankfurt, Germany

Agata Szeliga, LLM
Partner, Soltysinski, Kawecki and Szelzak, Warsaw, Poland

Michele Tagliaferri, Esq.
Partner, Sidley Austin LLP, Brussels, Belgium

Melda Tanyeri, MS, MBA
Director, Fraud Investigation & Dispute Services, EY, London, UK

Tamara Tubin
Compliance Director, Business Support EUCAN, Takeda Pharmaceuticals International AG, Switzerland

Dr. Mirjam Weisse, JD
Senior Director, Head of Compliance EMEA, Merz Pharma GmbH & Co, KGaA, Frankfurt, Germany

Mariusz Witalis
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland


DOWNLOAD THE CONFERENCE APP
Click here to download the conference app.
BROCHURE NOW AVAILABLE
Click here to download
the brochure.
SPONSORED BY:


CO-SPONSORS:




CO CHAIRS

Dr. Michael Bartke
Director Compliance Management, DAIICHI SANKYO EUROPE GmbH, Munich, Germany

Ann Beasley
Chief Compliance Officer, Biogen, Former Global Compliance Officer, Novartis Pharma AG, Board Member and Co-chair, Strategic Committee International Society of Healthcare, Ethics, and Compliance Professionals (ETHICS), Cambridge, MA, USA

Stephen Nguyen Duc
Office of Ethics & Compliance Area Director, International Operations, Western Europe & Canada, AbbVie, Board Member, Strategic Committee International Society of Healthcare, Ethics, and Compliance Professionals (ETHICS), Rungis, France

Dominique Laymand, Esq.
Senior Vice President, Chief Ethics and Compliance Officer, Ipsen; President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France

Roeland Van Aelst
Regional Vice President - HCCO MD&D EMEA & Canada, Office Health Care Compliance and Privacy, Johnson & Johnson, Co-chair, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Chairman, MedTech Compliance Network, Brussels, Belgium

GRANTORS:
DIAMOND


SILVER


BRONZE




















CONTINUING EDUCATION CREDITS
Accounting Professionals: Approved for up to 19 NASBE CPE credits.

Compliance Professionals: Approved for up to 18.50 Compliance Certification Board CCB Credits.

Attorneys: The Congress is currently pending approval to offer Pennsylvania MCLE Credit.

Click here for more information.

FOLLOW INTERNATIONAL PHARMA CONGRESS ON




Tweet using #PharmaCongress

OTHER INTERNATIONAL PHARMA CONGRESSES

2007 - Brussels


2008 - Paris


2009 - Rome


2010 - Berlin


2011 - Istanbul


2011 - Singapore


2012 - Budapest


2012 - Shanghai


2012 - São Paulo


2013 - Madrid, Spain


2013 - Kuala Lumpur


2014 - Dubai


2014 - Mexico City


2014 - Shanghai


2015 - Manila

PARTICIPATION OPTIONS
TRADITIONAL ONSITE ATTENDANCE
Simply register, travel to the conference city and attend in person.

Pros: subject matter immersion; professional networking opportunities; faculty interaction



THE 2015 NINTH INTERNATIONAL PHARMA CONGRESS CONTENT IS NOW AVAILABLE IN VARIOUS POST CONFERENCE FORMATS

The 2015 Ninth International Pharma Congress conference content is now available in a variety of formats.

You may purchase the Congress streaming content in the following formats: Flash Drive or online archive (6 months). You may also purchase individual presentations in an online archive (6 months) format.

YOU CAN PURCHASE JUST THE INTERNATIONAL PHARMA CONGRESS CONTENT AS FOLLOWS:

Online Archive of 2015 Ninth International Pharma Congress Presentations today!
Complete conference: $595
Order Now

Flash Drive of 2015 Ninth International Pharma Congress Presentations today!
$595
Order Now

FINALLY YOU MAY PURCHASE INTERNATIONAL PHARMA CONGRESS INDIVIDUAL PRESENTATIONS:
Click here to purchase individual presentations for $59.95 in online archive format (6 months of access - 24/7).




2016 GLOBAL PHARMA COMPLIANCE CONGRESSES

SEVENTEENTH PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Transformational Learning - Effective Knowledge Exchange
Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
October 19 - 21, 2016
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
SIXTH ASIA PACIFIC
PHARMACEUTICAL
COMPLIANCE CONGRESS

A Hybrid Conference and Internet Event
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
Media Partners: Life Sciences Compliance Update
September 21 - 23, 2016
Shangri-La Hotel
Singapore
www.AsianPharmaCongress.com
PHARMACEUTICAL SUMMIT ON BUSINESS AND COMPLIANCE ISSUES IN MANAGED MARKETS
The Leading Forum on Pharmaceutical Market Access, Reimbursement, Pricing, and Contracting with Commercial and Government Payers
Co-located with Eighth National Medical Home, Sixth Bundled Payment Summit and Seventh National ACO Summit
Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
June 8 - 9, 2016
Grand Hyatt
Washington, DC
www.PharmaManagedMarketsSummit.com




Overview | Agenda | Promotional Opportunities | Grantors & Exhibitors
Admin | Speaking Proposals | Continuing Education | Past Conferences | Contact Us | Home




© Health Care Conference Administrators
Contact Webmaster